Understanding and Challenges in Taking Tyrosine Kinase Inhibitors among Malaysian Chronic Myeloid Leukemia Patients: A Qualitative Study

BACKGROUND: In Malaysia, the treatment for chronic myeloid leukemia (CML) has long been delivered under the Malaysian Patient Assistance Program (MYPAP), but research on identifying factors contributing to non-adherence to tyrosine kinase inhibitors (TKIs) is still limited. The current study explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Yik Ming, Eng, Wei Lerk, Chan, Huan Keat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648400/
https://www.ncbi.nlm.nih.gov/pubmed/28749622
http://dx.doi.org/10.22034/APJCP.2017.18.7.1925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648400/
https://www.ncbi.nlm.nih.gov/pubmed/28749622
http://dx.doi.org/10.22034/APJCP.2017.18.7.1925

Ejemplares similares